Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss. In the published literature, the hypothesis is often made that IOP control implies a single IOP measurement over time. Although the follow-up of glaucoma patients with single IOP measurements is quick and convenient, such measurements often do not adequately reflect the untreated IOP characteristics, or indeed the quality of treated IOP control during the 24-h cycle. Since glaucoma is a 24-h disease and the damaging effect of elevated IOP is continuous, it is logical that we should aim to understand the efficacy of all treatment options throughout the 24-h period. This article first reviews the concept and value of diurnal and 24-h IOP monitoring. It then critically evaluates selected available evidence on the 24-h efficacy of medical, laser and surgical therapy options. During the past decade several controlled trials have significantly enhanced our understanding on the 24-h efficacy of all glaucoma therapy options. Nevertheless, more long-term evidence is needed to better evaluate the 24-h efficacy of glaucoma therapy and the precise impact of IOP characteristics on glaucomatous progression and visual prognosis.

Konstas, A., Quaranta, L., Bozkurt, B., Katsanos, A., Garcia-Feijoo, J., Rossetti, L., et al. (2016). 24-h Efficacy of Glaucoma Treatment Options. ADVANCES IN THERAPY, 33(4), 481-517 [10.1007/s12325-016-0302-0].

24-h Efficacy of Glaucoma Treatment Options

Miglior S.
2016

Abstract

Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss. In the published literature, the hypothesis is often made that IOP control implies a single IOP measurement over time. Although the follow-up of glaucoma patients with single IOP measurements is quick and convenient, such measurements often do not adequately reflect the untreated IOP characteristics, or indeed the quality of treated IOP control during the 24-h cycle. Since glaucoma is a 24-h disease and the damaging effect of elevated IOP is continuous, it is logical that we should aim to understand the efficacy of all treatment options throughout the 24-h period. This article first reviews the concept and value of diurnal and 24-h IOP monitoring. It then critically evaluates selected available evidence on the 24-h efficacy of medical, laser and surgical therapy options. During the past decade several controlled trials have significantly enhanced our understanding on the 24-h efficacy of all glaucoma therapy options. Nevertheless, more long-term evidence is needed to better evaluate the 24-h efficacy of glaucoma therapy and the precise impact of IOP characteristics on glaucomatous progression and visual prognosis.
Articolo in rivista - Articolo scientifico
24-h efficacy; 24-h intraocular pressure control; Circadian intraocular pressure characteristics; Diurnal intraocular pressure; Glaucoma therapy options; Intraocular pressure monitoring; Ophthalmology;
English
2016
33
4
481
517
partially_open
Konstas, A., Quaranta, L., Bozkurt, B., Katsanos, A., Garcia-Feijoo, J., Rossetti, L., et al. (2016). 24-h Efficacy of Glaucoma Treatment Options. ADVANCES IN THERAPY, 33(4), 481-517 [10.1007/s12325-016-0302-0].
File in questo prodotto:
File Dimensione Formato  
10281-280564.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 768.44 kB
Formato Adobe PDF
768.44 kB Adobe PDF Visualizza/Apri
Konstas2016_Article_24-hEfficacyOfGlaucomaTreatmen.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 768.44 kB
Formato Adobe PDF
768.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/280564
Citazioni
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 30
Social impact